NeuroSearch A/S | Income Statement

Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
28,756.00
-
-
-
-
Gross Income
28,756.00
-
-
-
-
SG&A Expense
38,371.00
13,266.00
6,488.00
7,634.00
3,202.00
EBIT
9,615.00
13,266.00
6,488.00
-
3,202.00
Unusual Expense
330.00
-
-
-
-
Non Operating Income/Expense
6,484.00
462.00
446.00
6,461.00
1,793.00
Interest Expense
2,322.00
-
-
-
-
Pretax Income
4,477.00
10,559.00
6,812.00
1,173.00
1,409.00
Income Tax
1,250.00
1,250.00
-
-
-
Equity in Affiliates
-
-
-
22,789.00
9,440.00
Consolidated Net Income
3,227.00
9,309.00
6,812.00
21,616.00
10,849.00
Net Income
3,227.00
9,309.00
6,812.00
21,616.00
10,849.00
Net Income After Extraordinaries
18,812.00
10,876.00
8,086.00
20,417.00
13,799.00
Net Income Available to Common
12,358.00
7,742.00
5,538.00
22,815.00
7,899.00
EPS (Basic)
0.50
0.32
0.23
0.94
0.33
Basic Shares Outstanding
24,554.00
24,554.00
24,288.10
24,288.00
24,288.00
EPS (Diluted)
0.50
0.32
0.23
0.94
0.33
Diluted Shares Outstanding
24,554.00
24,554.00
24,288.10
24,288.00
24,288.00
EBITDA
9,615.00
13,266.00
6,488.00
7,634.00
3,202.00
Non-Operating Interest Income
646.00
2,245.00
122.00
-
-

About NeuroSearch A/S

View Profile
Address
Strandvejen 60
Hellerup SD 2900
Denmark
Employees -
Website http://www.neurosearch.com
Updated 09/14/2018
NeuroSearch A/S engages in the research, development, manufacture, and trading of drugs for the treatment of central nervous system conditions. The company was founded by Jørgen Buus Lassen in 1989 and is headquartered in Hellerup, Denmark. .